Clinical significance of blood endocan level in breast cancer patients-Reference-Cited by-同舟云学术

Clinical significance of blood endocan level in breast cancer patients

Published:2023 Issue:2 Volume:35 Page:98-102
ISSN:0915-6380
Container-title:The Showa University Journal of Medical Sciences
language:en
Short-container-title:Showa Univ J Med Sci

Author:

Kanada Yoko¹,Daiki Kentaro²,Nagata Aya³,Taruno Kanae³,Kuwayama Takashi³,Hashimoto Rikako³,Masuda Hiroko³,Akashi-Tanaka Sadako³,Nakamura Seigo³,Kato Yoshinori²

Affiliation:

1. Breast Surgical Oncology, Surgery Center, Showa University Fujigaoka Hospital

2. Laboratory of Biopharmaceutics and Analytical Science, Hoshi University School of Pharmacy and Pharmaceutical Sciences

3. Department of Surgery, Division of Breast Surgery, Showa University School of Medicine

Publisher

The Showa University Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/sujms/35/2/35_98/_pdf

Reference14 articles.

1. 1. Mirabelli P, Incoronato M. Usefulness of traditional serum biomarkers for management of breast cancer patients. Biomed Res Int. 2013;2013:685641.

2. 2. Nielsen TO, Leung SCY, Rimm DL, et al. Assessment of Ki67 in breast cancer: Updated recommendations from the international Ki67 in breast cancer working group. J Natl Cancer Inst. 2021;113:808-819.

3. 3. Bechard D, Gentina T, Delehedde M, et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001;276:48341-48349.

4. 4. Lassalle P, Molet S, Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271:20458-20464.

5. 5. Kim KH, Lee HH, Yoon YE, et al. Clinical validation of serum endocan （ESM-1） as a potential biomarker in patients with renal cell carcinoma. Oncotarget. 2017;9:662-667.